CLNNClene Inc.

CLNN Stock Price, Valuation & Chart | Clene Inc.

Compare

$4.160+0.06 (+1.34%)

At close · 02 Sept 2026, 08:00 pm

Sector: Healthcare Industry: Biotechnology CLNN intrinsic value CLNN calculated fair value vs price

Overview Financials Dividends Ratios

CLNN Historical price chart

CLNN Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization53.16M

PE Ratio-1.17

EPS-3.55

Trading Volume106.53K

Today's High/Low4.28/3.89

Dividend Yield0.00

52 Week High/Low13.5/3.88

Shares Outstanding12.78M

CLNN Financial Statement

CLNN Analyst ratings

CLNN Analysis & performance metrics

CLNN Company profile

Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics.…

Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a Phase 2/3 registrational clinical trial for patients with amyotrophic lateral sclerosis (ALS); completed Phase 2 proof of…

CLNN Management team

Name

Position

Benjamin M. Greenberg M.D., M.H.S.

Head of Medical

Jerry Miraglia J.D.

General Counsel & Corporate Secretary

Morgan R. Brown CPA, M.B.A.CFO

Chief Financial Officer

Mary Anne Mcneil

Head of Human Resources

Michael T. Hotchkin

Chief Development Officer

Mark G. Mortenson ESQ.

Chief Science Officer

Robert Etherington MBACEO

Chief Executive Officer, President & Director

Name

Position

Benjamin M. Greenberg M.D., M.H.S.

Head of Medical

Jerry Miraglia J.D.

General Counsel & Corporate Secretary

Morgan R. Brown CPA, M.B.A.CFO

Chief Financial Officer

Mary Anne Mcneil

Head of Human Resources

Michael T. Hotchkin

Chief Development Officer

Mark G. Mortenson ESQ.

Chief Science Officer

Robert Etherington MBACEO

Chief Executive Officer, President & Director

Management Team

Benjamin M. Greenberg M.D., M.H.S.

Head of Medical

Jerry Miraglia J.D.

General Counsel & Corporate Secretary

Morgan R. Brown CPA, M.B.A.CFO

Chief Financial Officer

Mary Anne Mcneil

Head of Human Resources

Michael T. Hotchkin

Chief Development Officer

Mark G. Mortenson ESQ.

Chief Science Officer

Robert Etherington MBACEO

Chief Executive Officer, President & Director

Management

Benjamin M. Greenberg M.D., M.H.S.

Head of Medical

Jerry Miraglia J.D.

General Counsel & Corporate Secretary

Morgan R. Brown CPA, M.B.A.CFO

Chief Financial Officer

Mary Anne Mcneil

Head of Human Resources

Michael T. Hotchkin

Chief Development Officer

Mark G. Mortenson ESQ.

Chief Science Officer

Robert Etherington MBACEO

Chief Executive Officer, President & Director

Total 7 executives

CLNN Frequently asked questions

What is Clene Inc. (CLNN) Stock Price?

Current stock price of Clene Inc. (CLNN) stock is $4.160. The stock price is +1.34% higher in the session. The intraday range can be seen from this page. Volume of Clene Inc. (CLNN) stock is 106.53K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Clene Inc. (CLNN) stock price going up or down today?

The stock price of Clene Inc. (CLNN) can change with earnings, company news, and overall market sentiment. Clene Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Clene Inc. stock expensive at its current price?

Whether Clene Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for CLNN on this page is -1.17. EPS on this page is -3.55. Compare those figures with peers and growth expectations before deciding if the current Clene Inc. price is justified.

How has the stock price of Clene Inc. (CLNN) performed historically?

Historical performance for Clene Inc. (CLNN) is shown on the price chart on this page. Review multi-period moves alongside volume to see how CLNN reacted to past earnings and market events.

Should I buy Clene Inc. (CLNN) stock, at this price?

Buying Clene Inc. (CLNN) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.